We are an ambitious cyanobacterial biologics platform company seeking an outstanding candidate for the role of Research Scientist.
As a highly-motivated individual, you will specialise in the development and testing of novel cyanobacterial biologics, including monoclonal antibodies, VLP vaccines, & therapeutic proteins.
You will tackle a range of challenges as an integral part of the team, and demonstrate a high degree of flexibility, creativity, and initiative.
You will have team leadership experience, be adaptable, work well collaboratively, and be able to thrive in a start-up environment.
Key Responsibilities Management of lab resources; overseeing smooth functioning of the lab & key processes Support in vitro & preclinical evaluation of biologics, in collaboration with biochemistry team & CTOWorking with downstream processing lead to coordinate analysis pipeline Updating CTO and Executive on status and timelines for biologics & preclinical material preparation Managing preclinical material production, in collaboration preclinical testing collaborators Education & Experience Critical BSc or MSc in, Bioscience, Biochemistry, Microbiology, Virology, Pharmacology, Immunology or closely-related area At least 1 year experience in experimental work within a life sciences laboratory, such as an academic faculty, research institute, biotechnology or pharmaceutical company Strong analytical and problem-solving skills Excellent documentation and communication skills, experience working in a team environment Advantageous but not essential: ELISA-based testing & in vitro/in vivo therapeutic characterisation Familiarity with m Ab and/or virus-like particle assembly and purification challenges Conducted preclinical development and/or delivery studies of m Abs, vaccines or therapeutic proteins Experience with mammalian cell culture & m Ab expression Understanding & experience of antibody biophysical characterisation techniques, such as disulfide bond formation, LC/HC assembly, and glycosylation About the Company Bondi Bio is an Australian biotechnology company developing a novel platform for the biomanufacture and delivery of biologics using bioengineered cyanobacteria.
The platform offers a cost-effective and rapidly-scalable solution to produce monoclonal antibodies, vaccines, and therapeutic proteins.
Bondi's food-grade cyanobacteria has the potential for distributed biomanufacturing and point-of-care needle-free delivery.
